Cyclosporine in psoriasis: Comparison of a 25-year real-world Italian experience to current european guidelines

Gianfranco Altomare, Fabio Ayala, Federico Bardazzi, Gilberto Bellia, Sergio Chimenti, Delia Colombo, Maria Laura Flori, Giampiero Girolomoni, Giuseppe Micali, Aurora Parodi, Ketty Peris, Gino A. Vena

Research output: Contribution to journalArticlepeer-review

Abstract

Cyclosporine (Csa) is an effective and safe therapeutic option in various dermatoses in both adults and children. over the last 25 years, Italian dermatologists have gained relevant experience about the use of Csa in the treatment of psoriasis and atopic dermatitis, and an Italian Consensus Conference has recently provided recommendations in adult patients. a comparison between these real-world indications and current european guidelines is hereby provided.

Original languageEnglish
Pages (from-to)432-435
Number of pages4
JournalGiornale Italiano di Dermatologia e Venereologia
Volume151
Issue number4
Publication statusPublished - Aug 1 2016

Keywords

  • Cyclosporine
  • Psoriasis
  • Skin diseases

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Cyclosporine in psoriasis: Comparison of a 25-year real-world Italian experience to current european guidelines'. Together they form a unique fingerprint.

Cite this